Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Eli Lilly's valuation is justified when you look at the growth profile, says UBS' Bristow
04:47pm, Thursday, 22'nd Sep 2022
Colin Bristow, UBS analyst, joins 'Closing Bell' to discuss the excitement around Eli Lilly's new diabetes drug, what goes into the $25 billion estimate that UBS has for the new drug and the company's
Eli Lilly (LLY) Gets FDA Nod for RET Inhibitor in Solid Tumors
03:03pm, Thursday, 22'nd Sep 2022
The FDA grants approval to Lilly's (LLY) Retevmo in advanced or metastatic solid tumors with a RET gene fusion. It converts the drug's accelerated approval in NSCLC indication to full approval.
UBS upgrades Eli Lilly declaring LLY is working on ‘the biggest drug ever'
10:33am, Thursday, 22'nd Sep 2022
UBS Group (SWX: UBSG), a global financial provider, upgraded Eli Lilly (NYSE: LLY) to buy from neutral on Tuesday, September
Eli Lilly Stock Rises on FDA Approval, Upgrade
10:03am, Thursday, 22'nd Sep 2022
Eli Lilly and Co (NYSE:LLY) is getting a boost today, after news that the U.S. Food & Drug Administration (FDA) approved its cancer drug Retevmo for new uses, including treatment of patients with a
UBS: LIlly's Type 2 diabetes and obesity treatment could be 'one of the best-selling drugs in history'
08:52am, Thursday, 22'nd Sep 2022
Shares of Eli Lilly & Co. Inc. LLY, -1.74% gained 2.5% in premarket trading on Thursday after UBS upgraded the stock to buy from neutral, saying Mounjaro, the company's newly approved Type 2 diabetes
3 Stocks That Could Rocket on Biden's Cancer Moonshot
04:18pm, Tuesday, 20'th Sep 2022
The idea that anyone could have a problem with Joe Biden's cancer moonshot is unimaginable. After all, who hasn't had a friend or relative affected by cancer?
7 Blue-Chip Stocks to Buy for Safety in This Volatile Market
04:14pm, Saturday, 17'th Sep 2022
I'm on the hunt for blue-chip stocks to buy for safety in this volatile market. The problem is the definition of what makes a company blue chip varies.
2 Top Healthcare Stocks to Buy for the Long Haul
10:45am, Friday, 16'th Sep 2022
Healthcare services never run out of style.
This Healthcare Company Is Likely To Offer Better Returns Over Eli Lilly Stock
09:00am, Thursday, 15'th Sep 2022
There is more to the comparison, and in the sections below, we discuss why we believe BDX stock will offer better returns than LLY stock in the next three years.
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
07:48am, Wednesday, 14'th Sep 2022
Shares in pharmaceutical giants including Roche, Novo Nordisk, Eli Lilly and AstraZeneca were little changed Wednesday despite getting a ratings boost from analysts at Berenberg, who cited respective
Eli Lilly and Company (LLY) Presents at Morgan Stanley 20th Annual Global Healthcare Conference (Transcript)
01:55pm, Tuesday, 13'th Sep 2022
Eli Lilly and Company (NYSE:LLY ) Morgan Stanley 20th Annual Global Healthcare Conference September 13, 2022 11:10 AM ET Company Participants Anat Ashkenazi - Senior Vice President and Chief Financial
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
04:49pm, Monday, 12'th Sep 2022
With the CHIPS Act and Inflation Reduction Act (IRA) safely behind him, President Joe Biden has set his sights on helping grow another sector. Today he signed an executive order for the launch of a ne
15 Stocks Billionaire Investors Agree It's Smart To Buy Now
08:00am, Monday, 12'th Sep 2022
Big investors are famous for breaking rank from the S&P 500 crowd. So when you see a few agreeing on a stock, it's worth paying attention.
Eli Lilly and Company (LLY) Citigroup 17th Annual BioPharma Conference (Transcript)
10:14pm, Wednesday, 07'th Sep 2022
Eli Lilly and Company (NYSE:LLY ) Citigroup 17th Annual BioPharma Conference Call September 7, 2022 3:30 PM ET Company Participants Dan Skovronsky - Chief Scientific Officer, Chief Medical Officer & P
Novo Nordisk, Eli Lilly Could Fatten Up on Weight-Loss Treatments
05:51pm, Wednesday, 31'st Aug 2022
Given that less than 3% of the 110 million obese Americans are being treated with drugs, new medications from Novo Nordisk AS ( NVO , Financial) and Eli Lilly and Co. ( LLY , Financial) could fatten t
